Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies
Phase II Study of Efficacy of ICI 182,780 (Faslodex) in the Treatment of Systemic Lupus Erythematosus: Clinical, Serologic, Molecular Phase II Study of Efficacy of ICI 182,780 (Faslodex) in the Treatment of Systemic Lupus Erythematosu ...
Systemic Lupus Erythematosus
Drug: ICI 182,780 (Faslodex)
The Center for Rheumatic Disease, Allergy, & Immunology